Cosmetic Product Registration in Japan: 2026 Import Guide

Japan remains one of the world’s most demanding and lucrative beauty markets, and importing cosmetics is a regulated process that rewards upfront compliance and punishes shortcuts. The single most important decision happens before shipment: how Japan classifies your product. The route for cosmetics is materially different from the route for quasi-drugs such as deodorants, anti-hair-loss products, depilatories, and certain medicated personal care items. Under Japan’s Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (the PMD Act), those two categories follow distinct approval and notification pathways, and getting the classification wrong can cost months of market entry time.

Is there a “cosmetic product registration” in Japan?

There is no single product registration for cosmetics in Japan. What most people mean by “cosmetic product registration” is a combination of three things under the PMD Act:

• A licensed Japan-side marketing authorization holder (化粧品製造販売業許可), the entity legally responsible for the product on the Japanese market. A foreign brand cannot hold this licence itself.
• A marketing notification (化粧品製造販売届) for each cosmetic product, filed by that licence holder with the prefectural authority before sale. This is a notification, not an approval.
• For quasi-drugs (医薬部外品) such as anti-hair-loss or deodorant products, a substantive approval (承認), reviewed by PMDA or the prefecture depending on category.

Get the classification right first; it decides which of these applies and how long the process takes. The steps below cover each in order.

Regulatory oversight of beauty products in Japan

The Ministry of Health, Labour and Welfare (MHLW) oversees the regulatory framework for cosmetics and quasi-drugs under the PMD Act. Technical review is handled by the Pharmaceuticals and Medical Devices Agency (PMDA) for many quasi-drug approvals, and prefectural authorities handle significant portions of licensing and inspection. The Consumer Affairs Agency is relevant for general advertising and labeling rules under the Act against Unjustifiable Premiums and Misleading Representations, and Japan Customs handles the border clearance dimension.

Note that the older term “Pharmaceutical Affairs Law” is outdated. Any checklists or distributor instructions still using that phrasing should be updated to refer to the PMD Act.

Classification comes first

Under the PMD Act:

• Cosmetics are products applied to the human body by rubbing, sprinkling, or similar means for the purpose of cleaning, beautifying, increasing attractiveness, altering appearance, or keeping skin or hair in good condition, with only mild effects on the human body.
• Quasi-drugs are products with mild effects that fall into specific regulated categories, including preventing bad breath or body odor, preventing heat rash or sores, preventing hair loss, promoting hair growth, and hair removal, among others.

The distinction matters because the compliance pathways diverge sharply. Cosmetics generally operate under a marketing notification system once the licensed marketing structure is in place. Quasi-drugs require a substantive approval, with review by PMDA and/or prefectural authorities depending on category.

A product marketed abroad as a “cosmetic” may not be a cosmetic in Japan if its ingredients, presentation, or intended claims push it into quasi-drug territory. This is the most common source of unexpected delay.

Step 1: Set up the correct Japan-side licensed structure

For commercial imports, the product cannot simply be shipped into Japan and sold. Japan Customs requires the relevant business licenses under the PMD Act and supporting documentation, and import permission is issued only after customs examination and confirmation of regulatory compliance.

In practice, foreign brands work through a Japan-based entity that holds the required licenses, typically:

• A Marketing Authorization Holder (MAH) license, which is the entity that takes regulatory responsibility for the products in Japan
• A Manufacturing License if any manufacturing (including labeling and secondary packaging) is done domestically
• An Importer (Primary Distributor) license, where relevant

The choice is usually between setting up the brand’s own licensed Japanese subsidiary or partnering with a licensed local distributor or contract MAH provider. This is not a simple “Importer of Record” question, the licensed Japan-side entity carries regulatory responsibility, not the foreign shipper.

Step 2: Check whether the overseas manufacturing site needs accreditation

If the product is manufactured outside Japan, the foreign manufacturing site may need to be accredited under Japan’s foreign manufacturer accreditation framework. PMDA administers this process, and the PMD Act’s enforcement rules provide specific accreditation requirements for overseas manufacturers of cosmetics and quasi-drugs.

Accreditation can take time. Review this at the outset, especially for a brand entering Japan for the first time, because it can directly affect launch timing.

Step 3: Review the formula against Japan’s Standards for Cosmetics

Before packaging or launch planning, the formula must be reviewed against the Standards for Cosmetics issued by MHLW, and against the positive/negative lists for ingredients. This covers:

• Prohibited ingredients (cannot be used)
• Restricted ingredients (usage limits)
• Preservatives, UV filters, and colorants (positive lists)
• Quasi-drug active ingredients (if the product is targeting quasi-drug classification)

Ingredients that are routine in other jurisdictions may be prohibited, restricted, or require reformulation for Japan. This review should happen before finalizing the launch schedule.

Step 4: Distinguish the cosmetics and quasi-drugs pathways

For standard cosmetics:

• Once the MAH and manufacturing/importation licenses are in place, products are generally handled through a notification system, not individual item-by-item approval
• Full ingredient labeling is typically required
• The scope of permitted efficacy claims is set by MHLW notice and is narrow

For quasi-drugs:

• Item-by-item approval is required
• PMDA and/or prefectural authorities conduct substantive review
• Permitted efficacy claims are specific to the quasi-drug category

Conflating the two pathways is a frequent source of project delay.

Step 5: Prepare compliant Japanese labeling and claims

Japan requires compliant Japanese-language labeling. Direct translation of foreign packaging is rarely sufficient.

A Japan-compliant label typically addresses:

• Product name
• Ingredient list (full disclosure for cosmetics)
• Warnings and directions
• Net content
• Manufacturing or expiration information as applicable
• The name and address of the Marketing Authorization Holder
• Country of origin where relevant

Efficacy claims must stay within the scope permitted for the category. MHLW notices define the permitted scope of claims for cosmetics and for each quasi-drug category. Beauty claims that are routine in Europe or North America (for example, anti-ageing, whitening beyond specific quasi-drug categories, skin-structure changes) are often non-compliant in Japan as cosmetic claims and either need to be reformulated, pursued as quasi-drugs, or removed.

Step 6: File the necessary notifications and import paperwork

Once the regulatory and licensing structure is in place, the importer prepares the required notifications and import documents so goods can clear customs. Japan Customs states that import declarations are submitted by the importer, typically via a customs broker, and import permission is issued after examination and satisfaction of applicable regulatory requirements.

The practical rule: regulatory preparation should be completed before goods arrive in Japan, not after.

Step 7: Do not confuse commercial and personal-use rules

Japan Customs permits limited private importation of cosmetics for personal use, generally up to 24 pieces of normal sizes per item. That exception does not apply to commercial imports for resale. Some online guides conflate the two, and that creates avoidable confusion. Businesses selling to Japanese consumers must follow the full PMD Act pathway.

What the official processing times actually are

Japan publishes a standard processing period (標準処理期間) for each administrative procedure, with its legal basis, fee status and annual filing volume. For the procedures a beauty importer touches:

Procedure	Legal basis	Standard period	Fee
Marketing authorisation renewal (製造販売業の許可の更新)	PMD Act, Art. 12(2)	20 days	yes
Manufacturing licence renewal (製造業の許可の更新)	PMD Act, Art. 13(4)	5 months	yes
Foreign manufacturer conformity inspection	PMD Act, Art. 14(7)	6 months	yes
Minor change notification (軽微な変更の届出)	PMD Act, Art. 14(16)	1 week	none
Partial change approval (一部変更承認)	PMD Act, Art. 14(15)	12 months	yes
Adverse reaction reporting	PMD Act, Art. 68(10)(1)	5 days	none

The last two lines are the ones to plan around. A minor change is a week; a partial change requiring fresh approval is twelve months. Which side of that line a product falls on is determined by decisions made early, about ingredients and claims, and is very difficult to revisit once a formulation and a claim set are locked. Classification is not a paperwork question. It is a schedule question with a fifty-fold range.

A note on published processing periods, which applies throughout. A standard processing period (標準処理期間) is set under Article 6 of the Administrative Procedure Act. That article obliges an agency to publish the period once it has set one, but setting it is only a best-efforts duty, and there is no statutory obligation to actually meet it. The clock also generally excludes time while an application sits with the applicant for correction.

How far target and outcome diverge is usually invisible, because completion dates are rarely published. In the one area where they are, the gap is substantial: every pesticide re-evaluation concluded to date has taken between 3.5 and 4.0 years against a published period of one year, a finding drawn from MAFF’s own records and set out in our guide to registering a pesticide in Japan. That multiple should not be assumed to apply here. What should be assumed is that a published period is a target, not a commitment, and that planning to it without contingency is optimistic.

Step 8: Plan the launch timeline around compliance, not logistics

For most beauty brands entering Japan, the biggest delays come from:

• Classification errors (cosmetic vs. quasi-drug)
• Claims that are too strong for the intended category
• Foreign manufacturer accreditation gaps
• Incomplete ingredient or formulation documentation
• Late-stage labeling revisions

A smoother Japan launch usually depends on answering these questions early:

• Is the product a cosmetic or a quasi-drug?
• Who is the licensed Japan-side responsible entity (MAH)?
• Does the overseas manufacturing site need accreditation?
• Does the formulation align with Japan’s Standards for Cosmetics?
• Are the Japanese label and claims compliant for the chosen category?
• Have the notifications and customs documents been prepared?

Common mistakes to avoid

• Assuming a product marketed as a cosmetic abroad is automatically a cosmetic in Japan
• Referring to the old “Pharmaceutical Affairs Law” instead of the PMD Act
• Treating the Japan-side importer as a pure logistics role rather than a licensed regulatory responsible party
• Skipping foreign manufacturer accreditation
• Translating foreign labels without a Japan-specific compliance review
• Carrying over efficacy claims that exceed the permitted scope for cosmetics
• Confusing personal-use import allowances with commercial import rules

Why this matters for public affairs in Japan

Beauty and cosmetics regulation intersects with MHLW policy cycles, industry association work through JCIA (Japan Cosmetic Industry Association), and Consumer Affairs Agency advertising rules. Brands entering Japan benefit from engagement not only with regulators but also with industry bodies shaping how standards evolve, particularly around new ingredients, claim categories, and digital marketing rules.

Gemini Group supports international beauty and cosmetics brands on regulatory strategy, PMD Act classification, MAH structuring, JCIA engagement, and policy monitoring in Japan. Contact us for a tailored review of your product and regulatory pathway.